Randomized trial of adjuvant chemotherapy versus concurrent chemoradiotherapy in early-stage cervical cancer after radical surgery: A Chinese Gynecologic Oncology Group study (CSEM-002)

被引:3
|
作者
Weng, D. [1 ]
Wang, H. [1 ]
Zhu, C. [2 ]
Cui, B. [3 ]
Wang, C. [1 ]
Li, K. [1 ]
Gao, Q. [1 ]
Cheng, X. [2 ]
Yang, X. [3 ]
Jiang, J. [3 ]
Zhang, Y. [3 ]
Kong, B. [3 ]
Xie, X. [2 ]
Ma, D. [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
关键词
D O I
10.1016/j.ygyno.2018.04.070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
59
引用
收藏
页码:30 / 30
页数:1
相关论文
共 50 条
  • [1] Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
    Danhui Weng
    Huihua Xiong
    Changkun Zhu
    Xiaoyun Wan
    Yaxia Chen
    Xinyu Wang
    Youzhong Zhang
    Jie Jiang
    Xi Zhang
    Qinglei Gao
    Gang Chen
    Hui Xing
    Changyu Wang
    Kezhen Li
    Yaheng Chen
    Yuyan Mao
    Dongxiao Hu
    Zimin Pan
    Qingqin Chen
    Baoxia Cui
    Kun Song
    Cunjian Yi
    Guangcai Peng
    Xiaobing Han
    Ruifang An
    Liangsheng Fan
    Wei Wang
    Tingchuan Xiong
    Yile Chen
    Zhenzi Tang
    Lin Li
    Xingsheng Yang
    Xiaodong Cheng
    Weiguo Lu
    Hui Wang
    Beihua Kong
    Xing Xie
    Ding Ma
    Frontiers of Medicine, 2023, 17 : 93 - 104
  • [2] Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
    Weng, Danhui
    Xiong, Huihua
    Zhu, Changkun
    Wan, Xiaoyun
    Chen, Yaxia
    Wang, Xinyu
    Zhang, Youzhong
    Jiang, Jie
    Zhang, Xi
    Gao, Qinglei
    Chen, Gang
    Xing, Hui
    Wang, Changyu
    Li, Kezhen
    Chen, Yaheng
    Mao, Yuyan
    Hu, Dongxiao
    Pan, Zimin
    Chen, Qingqin
    Cui, Baoxia
    Song, Kun
    Yi, Cunjian
    Peng, Guangcai
    Han, Xiaobing
    An, Ruifang
    Fan, Liangsheng
    Wang, Wei
    Xiong, Tingchuan
    Chen, Yile
    Tang, Zhenzi
    Li, Lin
    Yang, Xingsheng
    Cheng, Xiaodong
    Lu, Weiguo
    Wang, Hui
    Kong, Beihua
    Xie, Xing
    Ma, Ding
    FRONTIERS OF MEDICINE, 2023, 17 (01) : 93 - 104
  • [3] Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
    Weng Danhui
    Xiong Huihua
    Zhu Changkun
    Wan Xiaoyun
    Chen Yaxia
    Wang Xinyu
    Zhang Youzhong
    Jiang Jie
    Zhang Xi
    Gao Qinglei
    Chen Gang
    Xing Hui
    Wang Changyu
    Li Kezhen
    Chen Yaheng
    Mao Yuyan
    Hu Dongxiao
    Pan Zimin
    Chen Qingqin
    Cui Baoxia
    Song Kun
    Yi Cunjian
    Peng Guangcai
    Han Xiaobing
    An Ruifang
    Fan Liangsheng
    Wang Wei
    Xiong Tingchuan
    Chen Yile
    Tang Zhenzi
    Li Lin
    Yang Xingsheng
    Cheng Xiaodong
    Lu Weiguo
    Wang Hui
    Kong Beihua
    Xie Xing
    Ma Ding
    Frontiers of Medicine, 2023, 17 (01) : 93 - 104
  • [4] A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)
    Furusawa, Akiko
    Takekuma, Munetaka
    Mori, Keita
    Usami, Tomoka
    Kondo, Eiji
    Nishio, Shin
    Nishino, Koji
    Miyamoto, Yuichiro
    Yoshimura, Ryoichi
    Watanabe, Miho
    Mikami, Mikio
    Enomoto, Takayuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (04) : 623 - 626
  • [5] A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy (CCRT) for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
    Furusawa, Akiko
    Takekuma, Munetaka
    Usami, Tomoka
    Kondo, Eiji
    Nishio, Shin
    Nishino, Koji
    Miyamoto, Yuichiro
    Yoshimura, Ryoichi
    Watanabe, Miho
    Mikami, Mikio
    Enomoto, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study
    Tu, Hua
    Huang, He
    Ouyang, Yi
    Liu, Qing
    Xian, Bingna
    Song, Kun
    Chen, Gang
    Shen, Yuanming
    Liu, Jihong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 129 - 133
  • [7] Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/ adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study
    Twu, Nae-Fang
    Ou, Yu-Che
    Liao, Cheng-I
    Chang, Wei-Yang
    Yang, Lan-Yan
    Tang, Yun-Hsin
    Chen, Tze-Chien
    Chen, Chi-Hau
    Chen, Tze-Ho
    Yeh, Lain-Shung
    Hsu, Shih-Tien
    Chen, Yu-Chieh
    Chang, Cheng-Chang
    Cheng, Ya-Min
    Huang, Chia-Yen
    Liu, Fu-Shing
    Lin, Yue-Shan
    Hsiao, Sheng-Mou
    Kan, Yuan-Yee
    Lai, Chyong-Huey
    SURGICAL ONCOLOGY-OXFORD, 2016, 25 (03): : 229 - 235
  • [8] Comment on: Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study
    Gomes Carneiro, Vandre Cabral
    SURGICAL ONCOLOGY-OXFORD, 2016, 25 (04): : 467 - 467
  • [9] Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer
    Junying, T.
    Jin, H.
    Jinjin, L.
    Xiping, O.
    Pujun, L.
    Xue, G.
    Qian, Z.
    Tingting, P.
    Hongfei, P.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 353 - 353
  • [10] Comparison of chemoradiotherapy with and without brachytherapy as adjuvant therapy after radical surgery in early-stage cervical cancer with poor prognostic factors An observational study
    Lan, Mei-Ling
    Yu, Xian
    Xiao, He
    Zhou, Peng
    Hu, Nan
    Liu, Yun
    Wang, Ge
    MEDICINE, 2017, 96 (46)